Innovative appliance for colostomy patients: an interventional prospective pilot study.


Journal

Techniques in coloproctology
ISSN: 1128-045X
Titre abrégé: Tech Coloproctol
Pays: Italy
ID NLM: 9613614

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 17 02 2019
accepted: 24 07 2019
pubmed: 23 8 2019
medline: 29 4 2020
entrez: 23 8 2019
Statut: ppublish

Résumé

The control of body waste emptying is a constant research topic in stoma care. The aim of this pilot study was to assess the efficacy and safety of an innovative colostomy appliance. An interventional prospective non-comparative pilot study was conducted in seven French centers. The study device is a new type of two-piece appliance including a base plate and a "capsule cap" (CC) composed of a capsule cover and a folded collecting bag. The device gently seals the stoma to provide stoma output control. When the bowel movement pressure increases the patient may control the deployment of the folded bag and collect stools. Patients with left-sided colostomy all using a flat appliance, were enrolled in a 2-week trial. Outcome measures were type of CC removal and peristomal fecal leaks while wearing the device. Of 30 patients (females 66.7%), with left-sided colostomy (permanent 76.7%), 23 (76.7%) completed the 2-week trial. A total of 472 CC changes were analyzed. of 404 (85.5%) CC changes reported in diaries, 302 (74.8%) were linked with stool and/or gas. In 244 (60.3%) changes, the patient controlled stoma bag deployment and it occurred with bowel emptying 301 (74.5%) times. No leaks around the appliance were observed in 400 (85.3%) changes. no serious adverse event occurred. Peristomal skin was not modified during the trial. In the short term this new device has provided an increased control over bowel emptying at no risk in half of the trial population suggesting that an alternative approach to bag wearing is achievable.

Sections du résumé

BACKGROUND BACKGROUND
The control of body waste emptying is a constant research topic in stoma care. The aim of this pilot study was to assess the efficacy and safety of an innovative colostomy appliance.
METHODS METHODS
An interventional prospective non-comparative pilot study was conducted in seven French centers. The study device is a new type of two-piece appliance including a base plate and a "capsule cap" (CC) composed of a capsule cover and a folded collecting bag. The device gently seals the stoma to provide stoma output control. When the bowel movement pressure increases the patient may control the deployment of the folded bag and collect stools. Patients with left-sided colostomy all using a flat appliance, were enrolled in a 2-week trial. Outcome measures were type of CC removal and peristomal fecal leaks while wearing the device.
RESULTS RESULTS
Of 30 patients (females 66.7%), with left-sided colostomy (permanent 76.7%), 23 (76.7%) completed the 2-week trial. A total of 472 CC changes were analyzed.
EFFICACY RESULTS
of 404 (85.5%) CC changes reported in diaries, 302 (74.8%) were linked with stool and/or gas. In 244 (60.3%) changes, the patient controlled stoma bag deployment and it occurred with bowel emptying 301 (74.5%) times. No leaks around the appliance were observed in 400 (85.3%) changes.
SAFETY RESULTS
no serious adverse event occurred. Peristomal skin was not modified during the trial.
CONCLUSIONS CONCLUSIONS
In the short term this new device has provided an increased control over bowel emptying at no risk in half of the trial population suggesting that an alternative approach to bag wearing is achievable.

Identifiants

pubmed: 31435844
doi: 10.1007/s10151-019-02059-x
pii: 10.1007/s10151-019-02059-x
pmc: PMC6791903
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

853-859

Investigateurs

M F Charenton (MF)
N Daumard-Pasquier (N)
C Duval (C)
I Fernandes (I)
M T Gatel (MT)
H Sim (H)
A Souaré (A)
A Tourrou (A)
E Trividic (E)

Références

Health Expect. 2017 Dec;20(6):1421-1427
pubmed: 28675608
Clin Colon Rectal Surg. 2017 Jul;30(3):162-171
pubmed: 28684933
Indian J Psychol Med. 2017 Jan-Feb;39(1):63-68
pubmed: 28250561
Br J Nurs. 2011 Jan 13-26;20(1):22, 24-8
pubmed: 21240135
Br J Surg. 1993 Jul;80(7):930-2
pubmed: 8369943
Br J Nurs. 2011 Sep 8-22;20(16):S4-6, S8-11
pubmed: 22096802
Health Qual Life Outcomes. 2005 Oct 12;3:62
pubmed: 16219109
Dis Colon Rectum. 2010 Oct;53(10):1422-31
pubmed: 20847625
Colorectal Dis. 2013 Nov;15(11):e692-8
pubmed: 23800245
Eur J Gastroenterol Hepatol. 2013 Jun;25(6):739-47
pubmed: 23325279
J Wound Ostomy Continence Nurs. 1997 Mar;24(2):92-7
pubmed: 9204858
Br J Dermatol. 2011 Feb;164(2):330-5
pubmed: 20973766
Inflamm Bowel Dis. 2014 Dec;20(12):2519-25
pubmed: 25222659
Health Psychol. 2017 Feb;36(2):143-151
pubmed: 27831706
PLoS One. 2012;7(5):e37813
pubmed: 22679479
Br J Nurs. 2009 May 14-27;18(9):530, 532, 534 passim
pubmed: 19448579
Br J Nurs. 2006 Mar 23-Apr 12;15(6):308-16
pubmed: 16628166

Auteurs

P-A Lehur (PA)

Department of colorectal surgery, Clinique de chirurgie digestive et endocrinienne, Centre Hospitalier Universitaire, University hospital of Nantes, 1, place Alexis Ricordeau, 44,035, Nantes, France. dr.pa.lehur@gmail.com.

J-B Deguines (JB)

Centre Hospitalier, Service Chirurgie Digestive, Boulogne sur Mer, France.

L Montagliani (L)

Hôpital d'Instruction des Armées Begin, Service de Chirurgie Viscérale et Digestive, Saint Mandé, France.

J-P Duffas (JP)

CHRU Rangueil, Service de Chirurgie Générale et Digestive, Toulouse, France.

L Bresler (L)

CHRU Brabois, Service de Chirurgie Digestive, Hépatobiliaire, Pancréatique, Endocrinienne et Cancérologique, Vandoeuvre Les Nancy, France.

F Mauvais (F)

CH Beauvais, Chirurgie viscérale et digestive, Beauvais, France.

K Boudjema (K)

CHU Pontchaillou, Service de Chirurgie Hépato-Biliaire et Digestive, Rennes, France.

E Chouillard (E)

Centre hospitalier, Service de Chirurgie Digestive Viscérale, Urologique et Plastique, Poissy/St Germain en Laye Hospital, Poissy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH